Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Poon

Showing results (431-440 of 516) with videos related to

Pageof 52
Sort By:
Transboundary and Emerging Diseases|March 16, 2017
Coronavirus infections in horses in Saudi Arabia and OmanM G Hemida, D K W Chu, R A P M Perera, et al.
Nature|May 15, 2020
Infection of dogs with SARS-CoV-2Thomas H C Sit, Christopher J Brackman, Sin Ming Ip, et al.
Emerging Microbes & Infections|January 9, 2023
Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020Ziqi Zhou, Abraham Ali, Elias Walelign, et al.
Nature|May 27, 2011
Long-term evolution and transmission dynamics of swine influenza A virusDhanasekaran Vijaykrishna, Gavin J D Smith, Oliver G Pybus, et al.
Diabetes|September 2, 2025
Effects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose ToleranceZhengli Bai, Ke Wang, Tiffany Yau, et al.
Nature Microbiology|September 19, 2018
Mini viral RNAs act as innate immune agonists during influenza virus infectionAartjan J W Te Velthuis, Joshua C Long, David L V Bauer, et al.
Plos Medicine|June 27, 2006
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsJan ter Meulen, Edward N van den Brink, Leo L M Poon, et al.
Journal of Virology|December 23, 2004
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumoniaPatrick C Y Woo, Susanna K P Lau, Chung-ming Chu, et al.
Emerging Infectious Diseases|April 26, 2021
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, ChinaDaniel K W Chu, Kenrie P Y Hui, Haogao Gu, et al.
Bioengineering & Translational Medicine|July 22, 2024
Engineering a "muco-trapping" ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19Karthik Tiruthani, Carlos Cruz-Teran, Jasper F W Chan, et al.
Pageof 52

Showing results (431-440 of 516) with videos related to

Sort By:
Pageof 52
Transboundary and Emerging Diseases|March 16, 2017
Coronavirus infections in horses in Saudi Arabia and OmanM G Hemida, D K W Chu, R A P M Perera, et al.
Nature|May 15, 2020
Infection of dogs with SARS-CoV-2Thomas H C Sit, Christopher J Brackman, Sin Ming Ip, et al.
Emerging Microbes & Infections|January 9, 2023
Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017-2020Ziqi Zhou, Abraham Ali, Elias Walelign, et al.
Nature|May 27, 2011
Long-term evolution and transmission dynamics of swine influenza A virusDhanasekaran Vijaykrishna, Gavin J D Smith, Oliver G Pybus, et al.
Diabetes|September 2, 2025
Effects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose ToleranceZhengli Bai, Ke Wang, Tiffany Yau, et al.
Nature Microbiology|September 19, 2018
Mini viral RNAs act as innate immune agonists during influenza virus infectionAartjan J W Te Velthuis, Joshua C Long, David L V Bauer, et al.
Plos Medicine|June 27, 2006
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsJan ter Meulen, Edward N van den Brink, Leo L M Poon, et al.
Journal of Virology|December 23, 2004
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumoniaPatrick C Y Woo, Susanna K P Lau, Chung-ming Chu, et al.
Emerging Infectious Diseases|April 26, 2021
Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, ChinaDaniel K W Chu, Kenrie P Y Hui, Haogao Gu, et al.
Bioengineering & Translational Medicine|July 22, 2024
Engineering a "muco-trapping" ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19Karthik Tiruthani, Carlos Cruz-Teran, Jasper F W Chan, et al.
Pageof 52